Serum metabolomics reveals systemic metabolic reprogramming associated with bullous pemphigoid
Archives of Dermatological Research · 14.11.2026 · 318 (1)
DOI: 10.1007/s00403-026-05006-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Dermatological Research, online erschienen am 14.11.2026. Verfasst von Jing Ni und 6 weiteren Autor:innen. Die Arbeit nennt 45 Literaturangaben. Gefördert von: Medical Cross-Special Seed Fund for Basic Frontier Innovation and Cross-Scientific Research, Suzhou Medical College, Soochow University.
Abstract (Originalsprache)
Bullous pemphigoid (BP) is an autoimmune subepidermal blistering disease characterized by autoantibody-mediated inflammation, yet its systemic metabolic alterations remain incompletely understood. In this study, we performed comprehensive serum metabolomic profiling of BP patients and healthy controls using ultra-high-performance liquid chromatography coupled with high-resolution mass spectrometry. Among 4288 detected metabolites, partial least squares-discriminant analysis revealed clear separation between the two groups, and 452 metabolites showed significant differential abundance. These metabolites were mainly related to carbohydrates, lipids, amino acids, and nucleotides. The altered metabolites were mainly distributed among carbohydrates, lipids, amino acids, and nucleotides. Pathway enrichment analysis identified coordinated perturbations in central energy metabolism, including glycolysis/gluconeogenesis, the pentose phosphate pathway, and the tricarboxylic acid cycle, as well as sulfur-containing amino acid metabolism, glutathione-related pathways, and lipid remodeling. Network-level analysis further showed decreased abundance of multiple glycolytic and TCA-cycle intermediates, broad remodeling of lysophospholipids, membrane phospholipids, and sphingolipid-associated signaling. These findings indicate that BP is associated with broad serum metabolic reprogramming involving energy metabolism, redox homeostasis, amino acid metabolism, and lipid signaling. Given the exploratory design and the limited availability of detailed clinical covariates, the present findings should be interpreted as hypothesis-generating rather than causal. This study provides a systematic serum metabolomic overview of BP and identifies candidate metabolic pathways for future mechanistic and biomarker-validation studies.
Förderung
- Medical Cross-Special Seed Fund for Basic Frontier Innovation and Cross-Scientific Research, Suzhou Medical College, Soochow University
Zitieren
APA
Ni, J., Zhu, Y., Bian, W., Xiao, H., Luo, Y., Song, X., & Song, Z. (2026). Serum metabolomics reveals systemic metabolic reprogramming associated with bullous pemphigoid. Archives of Dermatological Research, 318(1). https://doi.org/10.1007/s00403-026-05006-7
Vancouver
Ni J, Zhu Y, Bian W, Xiao H, Luo Y, Song X, et al. Serum metabolomics reveals systemic metabolic reprogramming associated with bullous pemphigoid. Archives of Dermatological Research. 2026;318(1). doi:10.1007/s00403-026-05006-7
BibTeX
@article{Ni2026,
author = {Ni, Jing and Zhu, Ying and Bian, Wei and Xiao, Hui and Luo, Ying and Song, Xiao-yao and Song, Zhi-qi},
title = {Serum metabolomics reveals systemic metabolic reprogramming associated with bullous pemphigoid},
journal = {Archives of Dermatological Research},
year = {2026},
volume = {318},
number = {1},
doi = {10.1007/s00403-026-05006-7}
}
EUVIMED